SEC Form 4 · accession 0001078782-18-001401
Zivo Bioscience, Inc. · ZIVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher D. Maggiore
Director · 10% Owner
Period of report
Dec 6, 2018
Accepted (ET)
Dec 10, 2018 · 2:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001101026
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 6, 2018 | P | 10,000 | $0.15 | A | 20,127,520 | D | |
| Common Stock | Dec 7, 2018 | P | 31,000 | $0.13 | A | 20,158,520 | D | |
| Common Stock | Dec 10, 2018 | P | 172,000 | $0.12 | A | 20,330,520 | D |
Table II — derivative securities
No Table II lines on this filing.